FLUORESCENT PROBES FOR SILVER ION DETECTION
20210170053 · 2021-06-10
Inventors
- Benzhong Tang (Hong Kong, CN)
- Sijie CHEN (Hong Kong, CN)
- Sheng XIE (Hong Kong, CN)
- Wenxiong WANG (Hong Kong, HK)
- Neng YAN (Hong Kong, CN)
- Alex Yu Hin WONG (Hong Kong, CN)
Cpc classification
G01N21/6428
PHYSICS
International classification
Abstract
Fluorescent probes for silver ion detection include organic, water-soluble compounds having aggregation-induced emission (AIE) characteristics. The probes can sense or detect silver ions through aggregation or a precipitation reaction between the silver ions and the organic compounds which induces fluorescence. The compounds are acidic, soluble in aqueous phase, and provide low background fluorescence in aqueous solutions.
Claims
1. A fluorescent probe for ionic silver detection, comprising a compound that exhibits aggregation induced emission properties, wherein the compound comprises one or more backbone structures selected from the group consisting of: ##STR00019## ##STR00020## wherein at least one of R, R′, R″ or R′″ is selected from the group consisting of ##STR00021## and wherein all other of the of R, R′, R″ and R′″ groups are selected from the group consisting of H, heteroatom, alkyl, unsaturated alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.
2. The probe according to claim 1, comprising one or more compounds selected from the group consisting of: ##STR00022##
3. A method of detecting for presence of silver ions in a solvent, comprising: contacting the compound of claim 1 with the solvent, the solvent being selected from the group consisting of natural water, industrial wasters, aqueous buffer solutions and biological samples; and then irradiating the solvent with ultraviolet light, wherein an observable emission indicates the presence of the silver ions.
4. A method of imaging ionic silver in vivo, comprising: administering the compound of claim 1 to an organism; and obtaining images of the organism while the compound is within the organism using fluorescence imaging.
5. A method of in-gel detection and separation of biological molecules in a sample, comprising: conducting gel electrophoresis to separate the biological molecules in the sample; staining the separated biological molecules with silver ions; staining the biological molecules with the compound of claim 1 after staining with silver ions; and conducting fluorescence imaging of the separated biological molecules after staining with the compound of claim 1, wherein at least one of the biological molecules is selected from the group consisting of proteins, nucleic acids, lipopolysaccharides, glycoproteins and polysaccharides.
6. A method of monitoring the release of silver ions from metallic silver, comprising: providing a sample comprising metallic silver in a medium; adding the compound of claim 1 to the medium; and conducting fluorescence imaging of the sample while the compound is in the medium to monitor the release of silver ions from the sample, wherein the sample is selected from the group consisting of a surface coating, a silver nanomaterial, and a drug.
7. The method of claim 6, wherein the compound aggregates as insoluble fluorescent nanoparticles when silver ions are present.
8. A fluorescent probe for ionic silver detection, comprising a compound that exhibits aggregation induced emission properties, wherein the compound comprises the following backbone structure: ##STR00023## wherein at least one of R, R′, R″ or R′″ is selected from the group consisting of ##STR00024## and wherein all other of the of R, R′, R″ and R′″ groups are selected from the group consisting of H, heteroatom, alkyl, unsaturated alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.
9. The probe according to claim 8, comprising one or more compounds selected from the group consisting of: ##STR00025##
10. A method of detecting for presence of silver ions in a solvent, comprising: contacting the compound of claim 8 with the solvent, the solvent being selected from the group consisting of natural water, industrial wastes, aqueous buffer solutions, and biological samples; and then irradiating the solvent with ultraviolet light, wherein an observable emission indicates the presence of the silver ions.
11. A method of imaging ionic silver in vivo, comprising: administering the compound of claim 8 to an organism; and obtaining images of the organism while the compound is within the organism using fluorescence imaging.
12. A method of in-gel detection and separation of biological molecules in a sample, comprising: conducting gel electrophoresis to separate the biological molecules in the sample; staining the separated biological molecules with silver ions; staining the biological molecules with the compound of claim 8 after staining with silver ions, and conducting fluorescence imaging of the separated biological molecules after staining with the compound of claim 8, wherein at least one of the biological molecules is selected from the group consisting of proteins, nucleic acids, lipopolysaccharides, glycoproteins and polysaccharides.
13. A method of monitoring the release of silver ions from metallic silver, comprising: providing a sample comprising metallic silver in a medium; adding the compound of claim 8 to the medium; and conducting fluorescence imaging of the sample while the compound is in the medium to monitor the release of silver ions from the sample, wherein the sample is selected from the group consisting of a surface coating, a silver nanomaterial, and a drug.
14. The method of claim 13, wherein the compound aggregates as insoluble fluorescent nanoparticles when silver ions are present.
15. A fluorescent probe for ionic silver detection, comprising: one or more compounds selected from the group consisting of: ##STR00026##
16. A method of detecting a presence of silver ions in a solvent, comprising: contacting the compound of claim 15 with the solvent, the solvent being selected from the group consisting of natural water, industrial wasters, aqueous buffer solutions and biological samples; and irradiating the solvent with ultraviolet light, wherein an observable emission indicates the presence of the silver ions.
17. A method of imaging ionic silver in vivo, comprising: administering the compound of claim 15 to an organism; and obtaining images of the organism while the compound is within the organism using fluorescence imaging.
18. A method of in-gel detection and separation of biological molecules in a sample, comprising: conducting gel electrophoresis to separate the biological molecules in the sample; staining the separated biological molecules with silver ions; staining the biological molecules with the compound of claim 15 after staining with silver ions, and conducting fluorescence imaging of the separated biological molecules after staining with the compound of claim 15, wherein at least one of the biological molecules is selected from the group consisting of proteins, nucleic acids, lipopolysaccharides, glycoproteins and polysaccharides.
19. A method of monitoring the release of silver ions from metallic silver, comprising: providing a sample comprising metallic silver in a medium; adding the compound of claim 15 to the medium; and conducting fluorescence imaging of the sample while the compound is in the medium to monitor the release of silver ions from the sample, wherein the sample is selected from the group consisting of a surface coating, a silver nanomaterial, and a drug.
20. The method of claim 19, wherein the compound aggregates as insoluble fluorescent nanoparticles when silver ions are present.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0023] Various embodiments will now be described in detail with reference to the accompanying drawings.
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
DETAILED DESCRIPTION
Definitions
[0038] The following definitions are provided for the purpose of understanding the present subject matter and for constructing the appended patent claims.
[0039] It is noted that, as used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise.
[0040] The term “λ.sub.ex” as used herein refers to excitation wavelength.
[0041] The phrase “aggregation caused quenching” or “ACQ” as used herein refers to the phenomenon wherein the aggregation of π-conjugated fluorophores significantly decreases the fluorescence intensity of the fluorophores. The aggregate formation is said to “quench” light emission of the fluorophores.
[0042] The phrase “aggregation induced emission” or “AIE” as used herein refers to the phenomenon manifested by compounds exhibiting significant enhancement of light-emission upon aggregation in the amorphous or crystalline (solid) states whereas they exhibit weak or almost no emission in dilute solutions.
[0043] “Emission intensity” as used herein refers to the magnitude of fluorescence/phosphorescence normally obtained from a fluorescence spectrometer or fluorescence microscopy measurement; “fluorophore” or “fluorogen” as used herein refers to a molecule which exhibits fluorescence; “luminogen” or “luminophore” as used herein refers to a molecule which exhibits luminescence; and “AIEgen” as used herein refers to a molecule exhibiting AIE characteristics.
[0044] As used herein, “halo” or “halogen” refers to fluoro, chloro, bromo, and iodo.
[0045] As used herein, “alkyl” refers to a straight-chain or branched saturated hydrocarbon group. Examples of alkyl groups include methyl (Me), ethyl (Et), propyl (e.g., n-propyl and z′-propyl), butyl (e.g., n-butyl, z′-butyl, sec-butyl, tert-butyl), pentyl groups (e.g., n-pentyl, z′-pentyl, -pentyl), hexyl groups, and the like. In various embodiments, an alkyl group can have 1 to 40 carbon atoms (i.e., C1-40 alkyl group), for example, 1-30 carbon atoms (i.e., C1-30 alkyl group). In some embodiments, an alkyl group can have 1 to 6 carbon atoms, and can be referred to as a “lower alkyl group”. Examples of lower alkyl groups include methyl, ethyl, propyl (e.g., n-propyl and z′-propyl), and butyl groups (e.g., n-butyl, z′-butyl, sec-butyl, tert-butyl). In some embodiments, alkyl groups can be substituted as described herein. An alkyl group is generally not substituted with another alkyl group, an alkenyl group, or an alkynyl group.
[0046] As used herein, “alkenyl” refers to a straight-chain or branched alkyl group having one or more carbon-carbon double bonds. Examples of alkenyl groups include ethenyl, propenyl, butenyl, pentenyl, hexenyl, butadienyl, pentadienyl, hexadienyl groups, and the like. The one or more carbon-carbon double bonds can be internal (such as in 2-butene) or terminal (such as in 1-butene). In various embodiments, an alkenyl group can have 2 to 40 carbon atoms (i.e., C2-40 alkenyl group), for example, 2 to 20 carbon atoms (i.e., C2-20 alkenyl group). In some embodiments, alkenyl groups can be substituted as described herein. An alkenyl group is generally not substituted with another alkenyl group, an alkyl group, or an alkynyl group.
[0047] As used herein, “heteroatom” refers to an atom of any element other than carbon or hydrogen and includes, for example, nitrogen, oxygen, silicon, sulfur, phosphorus, and selenium.
[0048] As used herein, “aryl” refers to an aromatic monocyclic hydrocarbon ring system or a polycyclic ring system in which two or more aromatic hydrocarbon rings are fused (i.e., having a bond in common with) together or at least one aromatic monocyclic hydrocarbon ring is fused to one or more cycloalkyl and/or cycloheteroalkyl rings. An aryl group can have 6 to 24 carbon atoms in its ring system (e.g., C6-24 aryl group), which can include multiple fused rings. In some embodiments, a polycyclic aryl group can have 8 to 24 carbon atoms. Any suitable ring position of the aryl group can be covalently linked to the defined chemical structure. Examples of aryl groups having only aromatic carbocyclic ring(s) include phenyl, 1-naphthyl (bicyclic), 2-naphthyl (bicyclic), anthracenyl (tricyclic), phenanthrenyl (tricyclic), pentacenyl (pentacyclic), and like groups. Examples of polycyclic ring systems in which at least one aromatic carbocyclic ring is fused to one or more cycloalkyl and/or cycloheteroalkyl rings include, among others, benzo derivatives of cyclopentane (i.e., an indanyl group, which is a 5,6-bicyclic cycloalkyl/aromatic ring system), cyclohexane (i.e., a tetrahydronaphthyl group, which is a 6,6-bicyclic cycloalkyl/aromatic ring system), imidazoline (i.e., a benzimidazolinyl group, which is a 5,6-bicyclic cycloheteroalkyl/aromatic ring system), and pyran (i.e., a chromenyl group, which is a 6,6-bicyclic cycloheteroalkyl/aromatic ring system). Other examples of aryl groups include benzodioxanyl, benzodioxolyl, chromanyl, indolinyl groups, and the like. In some embodiments, aryl groups can be substituted as described herein. In some embodiments, an aryl group can have one or more halogen substituents, and can be referred to as a “haloaryl” group. Perhaloaryl groups, i.e., aryl groups where all of the hydrogen atoms are replaced with halogen atoms (e.g., —C.sub.6F.sub.5), are included within the definition of “haloaryl”. In certain embodiments, an aryl group is substituted with another aryl group and can be referred to as a biaryl group. Each of the aryl groups in the biaryl group can be substituted as disclosed herein.
[0049] As used herein, “heteroaryl” refers to an aromatic monocyclic ring system containing at least one ring heteroatom selected from oxygen (O), nitrogen (N), sulfur (S), silicon (Si), and selenium (Se) or a polycyclic ring system where at least one of the rings present in the ring system is aromatic and contains at least one ring heteroatom. Polycyclic heteroaryl groups include those having two or more heteroaryl rings fused together, as well as those having at least one monocyclic heteroaryl ring fused to one or more aromatic carbocyclic rings, non-aromatic carbocyclic rings, and/or non-aromatic cycloheteroalkyl rings. A heteroaryl group, as a whole, can have, for example, 5 to 24 ring atoms and contain 1-5 ring heteroatoms (i.e., 5-20 membered heteroaryl group). The heteroaryl group can be attached to the defined chemical structure at any heteroatom or carbon atom that results in a stable structure. Generally, heteroaryl rings do not contain O—O, S—S, or S—O bonds. However, one or more N or S atoms in a heteroaryl group can be oxidized (e.g., pyridine N-oxide thiophene S-oxide, thiophene S,S-dioxide). Examples of heteroaryl groups include, for example, the 5- or 6-membered monocyclic and 5-6 bicyclic ring systems shown below: where T is O, S, NH, N-alkyl, N-aryl, N-(arylalkyl) (e.g., N-benzyl), SiH.sub.2, SiH(alkyl), Si(alkyl).sub.2, SiH(arylalkyl), Si(arylalkyl).sub.2, or Si(alkyl)(arylalkyl). Examples of such heteroaryl rings include pyrrolyl, furyl, thienyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, triazolyl, tetrazolyl, pyrazolyl, imidazolyl, isothiazolyl, thiazolyl, thiadiazolyl, isoxazolyl, oxazolyl, oxadiazolyl, indolyl, isoindolyl, benzofuryl, benzothienyl, quinolyl, 2-methylquinolyl, isoquinolyl, quinoxalyl, quinazolyl, benzotriazolyl, benzimidazolyl, benzothiazolyl, benzisothiazolyl, benzisoxazolyl, benzoxadiazolyl, benzoxazolyl, cinnolinyl, 1H-indazolyl, 2H-indazolyl, indolizinyl, isobenzofuyl, naphthyridinyl, phthalazinyl, pteridinyl, purinyl, oxazolopyridinyl, thiazolopyridinyl, imidazopyridinyl, furopyridinyl, thienopyridinyl, pyridopyrimidinyl, pyridopyrazinyl, pyridopyridazinyl, thienothiazolyl, thienoxazolyl, thienoimidazolyl groups, and the like. Further examples of heteroaryl groups include 4,5,6,7-tetrahydroindolyl, tetrahydroquinolinyl, benzothienopyridinyl, benzofuropyridinyl groups, and the like. In some embodiments, heteroaryl groups can be substituted as described herein.
[0050] As used herein, a “donor” material refers to an organic material, for example, an organic nanoparticle material, having holes as the majority current or charge carriers.
[0051] As used herein, an “acceptor” material refers to an organic material, for example, an organic nanoparticle material, having electrons as the majority current or charge carriers.
[0052] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which the presently described subject matter pertains.
[0053] Where a range of values is provided, for example, concentration ranges, percentage ranges, or ratio ranges, it is understood that each intervening value, to the tenth of the unit of the lower limit, unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the described subject matter. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges, and such embodiments are also encompassed within the described subject matter, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the described subject matter.
[0054] Throughout the application, descriptions of various embodiments use “comprising” language. However, it will be understood by one of skill in the art, that in some specific instances, an embodiment can alternatively be described using the language “consisting essentially of” or “consisting of”.
[0055] For purposes of better understanding the present teachings and in no way limiting the scope of the teachings, unless otherwise indicated, all numbers expressing quantities, percentages or proportions, and other numerical values used in the specification and claims, are to be understood as being modified in all instances by the term “about”. Accordingly, unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained. At the very least, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
[0056] Compounds
[0057] Aggregation-induced emission is a relatively new concept of responsive fluorescence. Unlike conventional luminophores, a typical AIE luminogen such as tetraphenylethylene (TPE) has a propeller-shaped, non-planar structure. In dilute solution, TPE molecules undergo intermolecular rotation, which consumes energy through non-radiative pathways and renders them non-luminescent. In the aggregated state, intermolecular rotations are restricted on account of the physical constraint from neighboring molecules (
[0058] Due to their facile synthesis and outstanding performance, TPE and its derivatives have been widely used to construct AIE luminogens for various applications, including chemosensing, bioimaging and smart optical materials. Some AIE luminogens for metal ion sensing, however, have had some difficulty in sensing silver ions.
[0059] Accordingly, the present subject matter contemplates organic, water-soluble compounds having aggregation-induced emission (AIE) characteristics. The compounds, also referred to herein as “tetrazole-functionalized AIE luminogens,” or “fluorescent probes” can sense or detect silver ions through aggregation or a precipitation reaction between the silver ions and the organic compounds which induces fluorescence. The compounds are acidic, have good solubility in the aqueous phase (in particular when a salt is formed in basic conditions), and provide low background fluorescence in aqueous solutions.
[0060] According to an embodiment, the compounds have a backbone structural formula selected from the group consisting of:
##STR00007## ##STR00008##
[0061] wherein at least one of R, R′, R″ or R′″ is selected from the group consisting of
##STR00009##
and wherein all other of the R, R′, R″ and R′″ groups are selected from the group consisting of H, heteroatom, alkyl, unsaturated alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.
[0062] According to an embodiment, the compounds have the following backbone structural formula:
##STR00010##
wherein at least one of R, R′, R″ or R′″ is selected from the group consisting of
##STR00011##
and wherein all other of the R, R′, R″ and R′″ groups are selected from the group consisting of H, heteroatom, alkyl, unsaturated alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl.
[0063] In an embodiment, the compounds are selected from:
##STR00012##
[0064] Synthesis
[0065] Synthesis of the compounds can be straightforward and accomplished using various synthetic pathways. Exemplary reaction schemes for preparing the present compounds are provided below:
##STR00013## ##STR00014## ##STR00015##
[0066] Brominated TPEs (TPE-Br and TPE-2Br) can be synthesized from diphenylmethane and corresponding brominated biphenyl ketone following a procedure reported in J Org Chem 2007, 72, 8054. TPE-4Br synthesis can include bromination of TPE, which can be accessed by the McMurry coupling of benzophenone in good yields. The addition of liquid bromide to TPE is an aromatic bromination. These brominated TPE derivatives can undergo nucleophillic aromatic substitution by using copper cyanide (CuCN) as the nucleophile in DMF at elevated temperatures, which results in replacement of the Br atoms with a —CN group. These CN-derivatized TPEs can be isolated at modest yields. In the final step, these CN-derivatized TPEs (TPE-CN, TPE-2CN and TPE-4CN) can be cycloadded with azido ions (N.sub.3.sup.−) to give the targeted tetrazole-tagged TPEs in good yields. The overall protocol to synthesize these tetrazole-derivatized TPEs is simple, efficient and does not require harsh conditions and specific reagents.
[0067] In an exemplary embodiment, the tetrazole functional moieties can be installed using a nitrile-azide cycloaddition, as shown below, with CN compounds accessed in stock or through the substitution reaction of halogen-substituted compounds:
##STR00016##
AIE Activity
[0068] The present compounds are strongly emissive in the solid state with good fluorescent quantum yields. The compounds are weakly emissive or non-emissive when dissolved in aqueous solutions. As described in detail herein, for example, TPE-1TTZ, TPE-2TTZ, and TPE-4TTZ exhibit strong blue-green emission with good fluorescent quantum yields (Qy: TPE-1TTZ 39.6%; TPE-2TTZ 36.2%; TPE-4TTZ 76.8%) in the solid state. In contrast, when these compounds are dissolved, the solutions only emit faint light (Qy<1%). The compounds dissolve well in alcohols. The compounds can be modestly dissolved (for TPE-4TTZ, up 100 μM in DI-water) in the aqueous phase. Furthermore by the addition of NaOH solutions, the formed salts dissolve well in the aqueous phase (for TPE-4TTZ, up to 1 M in water). The freely-dissolved aqueous solutions are not emissive, which further demonstrates the AIE properties of the present compounds.
[0069] Reaction with Silver
[0070] As shown in
##STR00017##
[0071] Tetrazole exists in two tautomeric forms (1H and 2H) and the two forms are in dynamic equilibrium. The resulting tetrazole-silver complexes are believed to exist in a polymeric coordination network, with silver binding in a mono-, bi- or tri-dentate format to the nitrogen centers through coordination. The complexes are sparingly soluble in many solutions.
Silver Detection
[0072] A method of detecting for presence of silver ions in a solvent can include contacting one or more of the tetrazole-functionalized AIE luminogens with a solvent and irradiating the solvent with ultraviolet light. An observable emission can indicate the presence of silver ions. The solvent can include at least one of natural water, industrial wastes, aqueous buffer solutions, and biological samples. According to an embodiment, the solvent has a pH>4.
[0073] A method of imaging ionic silver in vivo can include administering one or more of the tetrazole-functionalized AIE luminogens to an organism and obtaining images of the organism while the compound is within the organism using fluorescence imaging.
[0074] When non-emissive aqueous solutions including TPE-4TTZ (e.g., 5 μM) were treated by addition of silver ions (e.g., 500 μM) and irradiated with UV light (e.g., under hand-held UV-lamp 350 nm irradiation), the solution became highly emissive. The turn-on fluorescence response was instant. The detection of silver ions was highly sensitive and sharp intensity changes could be detected with the naked eye. DLS (Dynamic light scattering) measurement confirmed the formation of nanoparticles. After evaporation of the fluorescent liquid, nano-sized particles (d=5˜30 nm) with even distribution were observed in SEM (
[0075] Referring to the above design, the tetrazole-Ag.sup.+ interaction mode below is proposed to explain the formation of a silver-TPE-4TTZ polymeric complex and result in silver ion detection in these cases.
##STR00018##
[0076] According to this model, silver ions in the solution undergo instant chelation with tetrazole units of the AIE probes. The chelation bridged by Ag.sup.+ then results in hardly soluble species for TPE-1TTZ, and/or most likely metallo supramolecular polymers when compound TPE-2TTZ and compound TPE-4TTZ are used. These species could efficiently form clusters, i.e., aggregates. As a result, these AIE-active molecules within aggregates show restricted motions, which lead to efficient emission.
[0077] In fluorescence spectroscopy, solutions containing silver ions behaved quite differently from solutions without silver ions in terms of intensity, with the ratio of intensity at maximum peak at 504 nm exceeding 400 times (
TABLE-US-00001 TABLE 1 Summary of silver sensing parameters. Excitation Emission LOD Linear Range (nm) (nm) (nM) (μM) TPE-1TTZ 345 490 1.5 0.1~3 TPE-2TTZ 345 489 3.0 0.2~10 TPE-4TTZ 345 504 2.3 0.04~15 LOD: limit of detection. Probes: 5 μM in DI-water. Measured by a Perkin-Elmer LS 55 spectrofluorometer.
[0078] A saturated PL intensity plateau was observed for all of the luminogens. The PL intensity is saturated when the ratio of [Ag.sup.+]:[TPE-4TTZ] approaches 4, and reaches maximum intensity when [Ag.sup.+]:[TPE-2TTZ] is 2.6 and [Ag.sup.+]:[TPE-1TTZ] is 0.6. This reveals that the maximum linear detection concentration of [Ag.sup.+] is related to the number of tetrazole moieties in the TPE-cored molecular probes. This is reasonable in view of the stoichiometric coordination interactions. The linear detection range is thus dependent on the concentration of the probe and can be further expanded by setting the concentrations of the probes (Table 1).
[0079] As selectivity is an important parameter for sensing technique, responses of these probes to other metal ions were examined.
[0080] The Ag.sup.+/Hg.sup.2+ coordination-induced fluorescence can be pH-sensitive. For example, with respect to TPE-4TTZ, a series of tests were done in phosphate buffer solutions at different pH varying from 4 to 12. At pH lower than 4, the tetrazole moiety (pKa˜4-5) was largely in the protonated form and sparingly soluble in solution and, thus, aggregated. The aggregation elicited fluorescence with a different color from that of the silver complexes. Therefore, the turn-on detection is only possible in solutions with pH>4. When pH is from 5˜6, PL response is significant enough for a high resolution detection of silver ions. To be noticed, when pH>6, the maximum PL response is relatively stable which demonstrates that the system is a robust sensing system for neutral to basic solutions. Furthermore regarding the mercury detection, the FL response was significant only at the pH window (4˜7); when pH>8, the fluorescence turn-on was not observed anymore. Thus, TPE-4TTZ is only sensitive to silver ions in basic solutions. Similar observations were made for the other tetrazole-tagged TPEs.
[0081] Detection can be based on selective coordination involving electrostatic interactions. Tests were conducted to determine whether silver binding moieties (e.g., anions) might be another kind of interfering factor in the mixture. In the test, silver ions were first mixed with the suspected interfering reagents (100 eq.) respectively including most anions, DNA/RNA bases and amino acids. After a short while of shaking, the probe (10 eq.) was added. Each solution was gently mixed and then checked in a PL machine. Compared with the control group, the interfering reagents including amino acids and DNA/RNA bases were only weakly interfering with the silver-tetrazole sensing process. In other words, the tetrazole anions can snatch silver ions from these ligands and elicit a fluorescence turn-on. There were exceptions, in particular for strong silver-interacting structures. Cysteine, the sulfur-containing amino acid, blocked sensing by the strong S—Ag interaction. Similar results were seen from SCN.sup.− and S.sub.2O.sub.3.sup.2-, due to their stronger binding affinity towards Ag.sup.+ than the tetrazole anion (CN.sub.4.sup.−). In addition, ammonium solution blocked sensing by reducing Ag.sup.+ into metallic silver. The results, provided in
Monitoring of Silver Ions Released from Metallic Silver
[0082] A method of monitoring release of silver ions from metallic silver can include providing a sample comprising metallic silver in a medium, adding one or more of the tetrazole-functionalized AIE luminogens to the medium, and conducting fluorescence imaging of the sample while the compound is in the medium to monitor the release of silver ions from the sample. The sample can be selected from a surface coating, a silver nanomaterial, and a drug. In an embodiment, the compound aggregates as insoluble fluorescent nanoparticles when silver ions are present.
[0083] The present compounds can sense silver ions instantaneously while being non-sensitive towards metallic silver. This property is ideal for monitoring of silver release from metallic silver. The TPE-4TTZ dye was tested to determine the dissolution kinetics of silver nanowires (AgNWs, 500 μg L.sup.−1) in SM7 medium. After the addition of the TPE-4TTZ probe to the fresh silver nanowire sample, the mixture was repeatedly monitored by PL machine at certain time-points. As shown in
[0084] The release of silver ions can be affected by many factors including the capping reagent and the size/shape of the metallic silver. The fluorescent method works well in these different cases. The silver sensing method described herein using the present compounds can be applied for various silver nanomaterials for monitoring their silver ion release profile at different conditions. As depicted in
TABLE-US-00002 TABLE 2 Dissolution half-life and ultimate silver ion concentration of different NPs using the ICP-MS method and the new method using TPE-4TTZ. Half-life [Ag.sup.+] at Size of release equilibrium Entry Surface (d) TPE-4TTZ ICP-MS TPE-4TTZ ICP-MS 1 Citrate 20 nm 5.7 h 4.7 h 35.5 h 31.3 h 2 Citrate 60 nm 13.2 h 6.8 h 55.9 h 44.6 h 3 Tween-20 60 nm 13.8 h 12.3 h 55.8 h 48.1 h
[0085] Fluorescent Silver Staining for in-Gel Detection of Proteins and Other Biological Molecules
[0086] A method of in-gel detection and separation of biological molecules in a sample can include conducting gel electrophoresis to separate the biological molecules in the sample; staining the separated biological molecules with silver ions; staining the biological molecules with one or more of the tetrazole-functionalized AIE luminogens after staining with silver ions; and conducting fluorescence imaging of the separated biological molecules after staining with the tetrazole-functionalized AIE luminogens. At least one of the biological molecules can be selected from proteins, nucleic acids, lipopolysaccharides, glycoproteins and polysaccharides.
[0087] In biological labs, silver staining has been routinely used for detection and separation of biological molecules. Silver staining is highly sensitive and, compared to other types of stainings, is generally considered to provide the best detection limits (for example LOD in SDS-PAGE Protein, 0.25 ng per band). Silver ions interact and bind selectively with biological functional groups including carboxyl groups, thiol-containing groups, and amine groups. In natural proteins, the strongest interactions occur with carboxylic acid groups (Asp and Glu), imidazole (His), sulfhydryls (Cys), and amines (Lys).
[0088] For classic silver staining, samples are first impregnated with Ag.sup.+, which are then reduced to metallic silver, resulting in a brown-black color to be visualized (
[0089] Classic silver staining using SYPRO® Ruby stain (
[0090] A procedure flow chart for the fluorescent silver staining in-gel detection method is depicted in
[0091] Apart from a higher sensitivity, the fluorescent silver staining protocol according to the present teachings has practical advantages compared to the conventional silver staining (
[0092] The present teachings are illustrated by the following examples.
EXAMPLES
Example 1
Synthesis
[0093] Synthesis of Tetraphenylethylene (TPE). Zinc dust (7.2 g) and dry THF (80 mL) were added into a two-necked round-bottom flask, which was vacuumed and purged with dry nitrogen 3 times. TiCl.sub.4 (6 mL) was then injected slowly into the flask over a period of 30 minutes. The ice-water bath was removed and the reaction mixture was refluxed for about 2 h. Benzophenone (5.0 g) was dissolved in dry THF (20 mL) and was added into the mixture slowly with a syringe. The mixture was refluxed overnight under nitrogen. After cooling to room temperature, the reaction mixture was quenched with (2 w %) HCl aqueous solution and was extracted with ethyl acetate and water (2×200 mL). The combined organic extracts were washed with distilled water, dried with anhydrous magnesium sulfate and filtrated. The solvent was removed with a rotary evaporator. The crude product was washed with ethanol and filtered to yield a white crystalline solid (3.7 g, 80%). .sup.1H NMR (CDCl.sub.3, 400 MHz) δ 7.05-7.08 (m, 8H), 7.10-7.13 (m, 12H); .sup.13C NMR (CDCl.sub.3, 100 MHz) δ 126.6, 127.8, 131.5, 141.1, 143.9.
[0094] Synthesis of Tetra(4-bromophenyl)ethylene (TPE-4Br). In a two-necked round bottom flask, tetraphenylethylene (2 g) was dissolved with glacial acetic acid (30 mL) in an ice-bath. Bromine (5 mL) was injected into the solution with a syringe over a 10 minute period followed by addition of dichloromethane (20 mL). After 15 minutes, the ice-water bath was removed and the resulting mixture was heated at 50° C. for about 15 minutes. The reaction mixture was added to 200 mL ice water, and the precipitated solid was filtered and washed repeatedly with water and ethanol until a light yellow color appeared. The yield of crude product was 1.65 g (43%). The product was used directly without further purification. .sup.1H NMR (CDCl.sub.3, 500 MHz): δ (ppm) 7.27 (d, J=8.5 Hz, 8H) and 6.85 (d, J=8.5 Hz, 8H).
[0095] Synthesis of Tetra(4-cyanophenyl)ethylene (TPE-4CN). TPE-4Br (6.67 g), CuCN (5.0 g, 56 mmol), and DMF (50 mL) were added into a two-necked round bottom flask. The mixture was heated at reflux for 60 hours under nitrogen conditions and then suspended into 300 mL of water. After ethylenediamine (10 mL) was added, the resulting mixture was stirred at 100° C. for 1 hour and was then filtered. The precipitated solid was extracted with dichloromethane (3×150 mL) and the combined organic phase was dried with anhydrous magnesium sulfate. After filtration and solvent evaporation, the residue was repeatedly purified by silica gel column chromatography with hexane and dichloromethane (v/v, 1/1) as eluent to give TPE-4CN 3.1 g in 70% yield as a white solid. .sup.1H NMR (CDCl.sub.3, 500 MHz): δ (ppm) 7.48 (t, J=5.0 Hz, 8H) and 7.08 (t, J=5.0 Hz, 8H). HRMS (MALDI-TOF), m/z calcd. for C.sub.30H.sub.16N.sub.4: 432.1375; found 432.1379.
[0096] Synthesis of TPE-4TTZ. Into a 25 mL round-bottomed flask were added sodium azide (1.12 g, 16 mmol), zinc bromide (450 mg, 2 eq.) and 2 mL of water. TPE-4CN (2 mmol) was dissolved in 10 mL of N-Methylpyrrolidone (NMP) and injected into the solution. The reaction mixture was refluxed for 24 hours with vigorous stirring at 150° C. The mixture was acidified to pH 1 with aqueous HCl solution (3 M) and was extracted into an organic layer with ethyl acetate (20 mL). The organic phase was washed with 3M HCl (2×10 mL) and solvent was evaporated to yield a crude product. This crude product was added into NaOH solution (0.25 M, 40 mL) and stirred vigorously until a white precipitate of zinc hydroxide was observed. The resulting suspension was filtered to remove zinc hydroxide. The filtrate was washed with ethylacetate (10 mL×2) and acidified to pH 1 with 3 M HCl. The tetrazole product precipitated upon stirring, which was again extracted into 20 mL ethyl acetate and the organic layer was separated. The aqueous layer was washed with ethyl acetate (20 mL×2). The organic layers were combined, concentrated and dried under vacuum to yield TPE-4TTZ (71%) as a yellowish solid. .sup.1H NMR (400 MHz, DMSO): δ 7.89 (d, 8H, J=8.2 Hz), 7.31 (d, 8H, J=8.2 Hz). HRMS (MALDI-TOF), m/z calcd. for C.sub.30H.sub.20N.sub.16Na.sup.+: 627.1949; found 627.1986 (M+Na.sup.+).
[0097] Synthesis of TPE-2Br. A solution of 2.2 M n-butyllithium in hexane (10 mL) and a solution of diphenylmethane (3.36 g, 20 mmol) in anhydrous tetrahydrofuran (50 mL) were added into a round-bottomed flask at 0° C. under an argon atmosphere. After stirring for 1 hour, bis(4-bromophenyl)methanone (5.4 g, 17 mmol) was added and the reaction mixture was allowed to warm to room temperature with stirring during a 10 hour period. The reaction was quenched with the addition of 10% sodium bicarbonate solution. The mixture was extracted with dichloromethane (3×50 mL) and the combined organic layers were dried with anhydrous magnesium sulfate. The solvent was evaporated to get the resulting crude alcohol. The crude alcohol was dissolved in 80 mL of toluene in a 100 mL flask. A catalytic amount of p-toluenesulfonic acid (0.68 g) was added and the mixture was refluxed for 12 hours. After the resulting mixture was cooled to room temperature, the toluene layer was washed with 10% aqueous sodium bicarbonate solution (2×25 mL) and dried over anhydrous magnesium sulfate and evaporated to afford the crude tetraphenyl-ethylene derivative (TPE-2Br, 3.6 g, 46%). HNMR (300 MHz, CDCl3) δ (ppm): 6.82-6.90 (m, 4H), 6.95-7.05 (s, 4H), 7.06-7.16 (s, 6H), 7.18-7.27 (m, 4H). CNMR (75 MHz, CDCl3) δ (ppm): 120.93, 127.10, 128.10, 131.30, 133.20, 138.55, 142.38, 143.40. HRMS (MALDI-TOF), m/z calcd. for C.sub.26H.sub.18Br.sub.2: 489.9755; found 489.9713.
[0098] Synthesis of TPE-2CN. TPE-2Br (975 mg, 2 mmol), CuCN (560 mg), and DMF (10 mL) were added into a two-necked round bottom flask. The mixture was heated at reflux for 60 hours under nitrogen condition and then suspended into 300 mL water. After ethylenediamine (10 mL) was added, the resulting mixture was stirred at 100° C. for 1 hour and was then filtered. The precipitated solid was extracted with dichloromethane (3×150 mL) and the combined organic phase was dried with anhydrous magnesium sulfate. After filtration and solvent evaporation, the residue was repeatedly purified by silica gel column chromatography with hexane and dichloromethane (v/v, 1/1) as eluent to give TPE-2CN in 53% yield. .sup.1H NMR (400 MHz, CDCl.sub.3): δ 7.45-7.42 (dm, 4H), 7.31 (m, 2H), 7.21-7.14 (m, 8H), 7.11 (dm, 4H). HRMS (MALDI-TOF), m/z calcd. for C.sub.28H.sub.18N.sub.2: 382.1470; found 382.1496.
[0099] Synthesis of TPE-2TTZ. Into a 25 mL flask were added sodium azide (300 mg), zinc bromide (450 mg) and 0.5 mL of water. TPE-2CN (250 mg) was dissolved in 4.5 mL of N-Methylpyrrolidone (NMP) and injected into the solution. The reaction mixture was stirred at 150° C. overnight. The mixture was acidified to pH 1 with aqueous HCl solution (3M) and was stirred vigorously for 30 minutes. The organic mixture was extracted with ethyl acetate (20 mL×2), washed with 3M HCl (50 mL×2) and concentrated to yield a crude product. This crude product was added into NaOH solution (0.25M, 40 mL) and stirred vigorously until a white precipitate of zinc hydroxide was observed. The resulting suspension was filtered to remove zinc hydroxide. The filtrate was washed with ethylacetate (10 mL×2) and acidified to pH 1 with 3 M HCl. The tetrazole product precipitated upon stirring, which was again extracted into 20 mL ethyl acetate and the organic layer was separated. The aqueous layer was washed with ethyl acetate (20 mL×2). The organic layers were combined, concentrated, and dried under vacuum to yield pure product (82%). .sup.1H NMR (400 MHz, CDCl.sub.3): δ (TMS, ppm) 9.92 (s, 1H), 7.51-7.45 (m, 5H), 7.35-7.34 (m, 2H), 7.25-7.23 (m, 3H), 3.84 (s, 3H). .sup.13C NMR (100 MHz, CDCl3): δ (TMS, ppm) 181.73, 142.42, 140.68, 135.09, 132.63, 129.83, 129.00, 128.64, 127.72, 126.79, 126.48, 32.28. HRMS (MALDI-TOF), m/z calcd. for C.sub.26H.sub.19Br: 410.0670; found 410.0677.
[0100] Synthesis of (2-(4-bromophenyl)ethene-1,1,2-triyl)tribenzene (TPE-Br). A solution of 2.5 M n-butyllithium in hexane (10 mL) and a solution of diphenylmethane (3.36 g) in anhydrous tetrahydrofuran (50 mL) were added into a round-bottomed flask at 0° C. under an argon atmosphere. After the resulting orange-red solution was stirred for 1 hour, (4-bromophenyl)(phenyl)methanone (4.4 g) was added and the reaction mixture was allowed to warm to room temperature with stirring during a 6 hours period. The reaction was quenched with the addition of 10% sodium chloride solution. The mixture was extracted with dichloromethane (3×50 mL) and the combined organic layers were dried with anhydrous magnesium sulfate. The solvent was evaporated to get the resulting crude alcohol. The crude alcohol was dissolved in 80 mL of toluene in a 250 mL flask. A catalytic amount of p-toluenesulfonic acid (680 mg) was added and the mixture was refluxed for 12 hours. After the resulting mixture was cooled down to room temperature, the toluene layer was washed with 10% aqueous sodium bicarbonate solution (2×25 mL), dried over anhydrous magnesium sulfate and evaporated to afford the crude tetraphenyl-ethylene derivative (TPE-Br, 63%). .sup.1H NMR (400 MHz, CDCl.sub.3): δ 6.88 (d, J=8.5 Hz, 2H), 7.00 (m, 6H), 7.09 (m, 9H), 7.20 (d, J=8.5 Hz, 2H); .sup.13C NMR (100 MHz, CDCl.sub.3): δ 120.6, 126.8, 126.8, 126.9, 127.9, 128.0, 128.1, 131.0, 131.42, 131.44, 131.5, 133.2, 139.8, 141.8, 142.9, 143.4, 143.5, 143.6. HRMS (MALDI-TOF), m/z calcd. for C.sub.26H.sub.19Br: 410.0670; found 410.0677.
[0101] Synthesis of 4-(1,2,2-triphenylvinyl)benzonitrile (TPE-CN). TPE-Br (820 mg), CuCN (268 mg), and DMF (10 mL) were added into a two-necked round bottom flask. The mixture was heated at reflux for 60 hours under nitrogen condition and then suspended into 300 mL water. After ethylenediamine (10 mL) was added, the resulting mixture was stirred at 100° C. for 1 hour and was then filtered. The precipitated solid was extracted with dichloromethane (3×150 mL) and the combined organic phase was dried with anhydrous magnesium sulfate. After filtration and solvent evaporation, the residue was purified by silica gel column chromatography with hexane and dichloromethane (v/v, 1/1) as eluent to give TPE-CN as white powder in 53% yield. .sup.1H NMR (400 MHz, CDCl.sub.3): δ 7.40 (d, 2H, J=8.4 Hz), 7.15 (m, 11H), 7.03 (m, 6H). .sup.13C NMR (100 MHz, CDCl3): δ 149.0, 143.5, 143.0, 142.9, 142.8, 139.3, 132.1, 131.7, 131.4, 131.3, 128.2, 128.0, 127.4, 127.2, 119.2, 110.0. HRMS (MALDI-TOF), m/z calcd. for C.sub.30H.sub.20N.sub.16Na.sup.+: 357.1517; found 357.1536.
[0102] Synthesis of TPE-1TTZ. Into a 10 mL round-bottomed flask were added sodium azide (138 mg, 2 mmol), zinc bromide (225 mg, 2 mmol) and 0.5 mL of water. TPE-CN (357 mg, 1 mmol) was dissolved in 4.5 mL of N-Methylpyrrolidone (NMP) and injected into the solution. The reaction mixture was stirred at 150° C. The mixture was acidified to pH 1 with aqueous HCl solution (3M) and was stirred vigorously for 30 minutes. The organic mixture was extracted with ethyl acetate (20 mL×2), washed with 3M HCl (50 mL×2) and concentrated to yield a crude product. This crude product was added into NaOH solution (0.25M, 40 mL) and stirred vigorously until a white precipitate of zinc hydroxide was observed. The resulting suspension was filtered to remove zinc hydroxide. The filtrate was washed with ethylacetate (10 mL×2) and acidified to pH 1 with 3 M HCl. The product precipitated upon stirring, which was again extracted into 20 mL ethyl acetate and the organic layer was separated. The aqueous layer was washed with ethyl acetate (20 mL×2). The organic layers were combined, concentrated and dried under vacuum to yield pure product as a white powder (82%). .sup.1H NMR (400 MHz, DMSO): δ 7.80 (d, 2H, J=8.4 Hz), 7.20-7.13 (m, 11H), 7.03-6.98 (m, 6H). HRMS (MALDI-TOF), m/z calcd. for C.sub.27H.sub.20N.sub.4: 400.1722; found 400.1762.
Example 2
Silver Ion Detection
[0103] Tetrazole-tagged AIE luminogen TPE-4TTZ (5 μM) undergoes a fluorescence turn-on response towards a solution of silver ions. The solutions can include organic solutions, aqueous solutions including natural water, wastes and/or biological buffer solutions. PL spectra were recorded on a Perkin-Elmer LS 55 spectrofluorometer.
[0104] With reference to
[0105] With reference to
Example 3
Monitoring of Silver Ion Release from Materials
[0106] With reference to
[0107] With reference to
Example 4
Fluorescent Silver Staining of in-Gel Protein Detection
[0108] With reference to
With reference to
[0116] The present subject matter being thus described, it will be apparent that the same may be modified or varied in many ways. Such modifications and variations are not to be regarded as a departure from the spirit and scope of the present subject matter, and all such modifications and variations are intended to be included within the scope of the following claims.